SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-060222
Filing Date
2020-11-24
Accepted
2020-11-24 16:39:11
Documents
2
Period of Report
2020-11-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1593
2 POA DOCUMENT poa.txt EX-24.3_946917 3635
  Complete submission text file 0001209191-20-060222.txt   6601
Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
Sepp-Lorenzino Laura (Reporting) CIK: 0001777421 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39536 | Film No.: 201344646

Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)